Aziyo Biologics Inc is a medical devices business based in the US. Aziyo Biologics shares (AZYO) are listed on the NASDAQ and all prices are listed in US Dollars. Aziyo Biologics employs 175 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Aziyo Biologics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AZYO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Aziyo Biologics stock price (NASDAQ: AZYO)Use our graph to track the performance of AZYO stocks over time.
Aziyo Biologics shares at a glance
|Latest market close||$5.53|
|52-week range||$5.37 - $16.72|
|50-day moving average||$7.52|
|200-day moving average||$9.58|
|Wall St. target price||$16.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.02|
Buy Aziyo Biologics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Aziyo Biologics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aziyo Biologics price performance over time
|1 week (2021-10-14)||2.98%|
|1 month (2021-09-22)||-26.46%|
|3 months (2021-07-22)||-32.64%|
|6 months (2021-04-22)||-55.65%|
|1 year (2020-10-21)||-51.41%|
|2 years (2019-10-18)||N/A|
|3 years (2018-10-18)||N/A|
|5 years (2016-10-18)||N/A|
Aziyo Biologics financials
|Revenue TTM||$49.3 million|
|Gross profit TTM||$20.6 million|
|Return on assets TTM||-15.81%|
|Return on equity TTM||-740.82%|
|Market capitalisation||$55.8 million|
TTM: trailing 12 months
Shorting Aziyo Biologics shares
There are currently 2,190 Aziyo Biologics shares held short by investors – that's known as Aziyo Biologics's "short interest". This figure is 77.6% down from 9,793 last month.
There are a few different ways that this level of interest in shorting Aziyo Biologics shares can be evaluated.
Aziyo Biologics's "short interest ratio" (SIR)
Aziyo Biologics's "short interest ratio" (SIR) is the quantity of Aziyo Biologics shares currently shorted divided by the average quantity of Aziyo Biologics shares traded daily (recently around 24333.333333333). Aziyo Biologics's SIR currently stands at 0.09. In other words for every 100,000 Aziyo Biologics shares traded daily on the market, roughly 90 shares are currently held short.
To gain some more context, you can compare Aziyo Biologics's short interest ratio against those of similar companies.
However Aziyo Biologics's short interest can also be evaluated against the total number of Aziyo Biologics shares, or, against the total number of tradable Aziyo Biologics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aziyo Biologics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Aziyo Biologics shares in existence, roughly 0 shares are currently held short) or 0.0014% of the tradable shares (for every 100,000 tradable Aziyo Biologics shares, roughly 1 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aziyo Biologics.
Find out more about how you can short Aziyo Biologics stock.
Aziyo Biologics share dividends
We're not expecting Aziyo Biologics to pay a dividend over the next 12 months.
Aziyo Biologics overview
Aziyo Biologics, Inc. , a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. The company also provides FiberCel, ViBone, and OsterGro V that are designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc.
Aziyo Biologics in the news
44 Biggest Movers From Yesterday
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Frequently asked questionsWhat percentage of Aziyo Biologics is owned by insiders or institutions?
Currently 8.754% of Aziyo Biologics shares are held by insiders and 93.28% by institutions. How many people work for Aziyo Biologics?
Latest data suggests 175 work at Aziyo Biologics. When does the fiscal year end for Aziyo Biologics?
Aziyo Biologics's fiscal year ends in December. Where is Aziyo Biologics based?
Aziyo Biologics's address is: 12510 Prosperity Drive, Silver Spring, MD, United States, 20904 What is Aziyo Biologics's ISIN number?
Aziyo Biologics's international securities identification number is: US05479K1060
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert